Published in Cancer Res on December 22, 2009
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 4.11
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest (2010) 2.37
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer (2010) 2.20
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer (2011) 2.02
MicroRNA in lung cancer. Br J Cancer (2010) 1.97
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun (2014) 1.95
Tumour angiogenesis regulation by the miR-200 family. Nat Commun (2013) 1.90
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res (2010) 1.89
Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst (2012) 1.85
Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer (2011) 1.74
Nanopore-based detection of circulating microRNAs in lung cancer patients. Nat Nanotechnol (2011) 1.68
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest (2011) 1.59
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer (2010) 1.56
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res (2010) 1.54
MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer (2012) 1.43
MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis (2012) 1.40
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol (2013) 1.31
A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One (2011) 1.28
Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One (2010) 1.27
Circulating microRNAs predict biochemical recurrence in prostate cancer patients. Br J Cancer (2013) 1.25
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol (2013) 1.25
Computational medicine: translating models to clinical care. Sci Transl Med (2012) 1.25
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues. PLoS One (2013) 1.24
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res (2013) 1.22
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
Increased microRNA-630 expression in gastric cancer is associated with poor overall survival. PLoS One (2014) 1.09
MicroRNAs as lung cancer biomarkers. World J Clin Oncol (2014) 1.07
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLoS One (2012) 1.07
miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. Development (2011) 1.04
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research. J Exp Clin Cancer Res (2011) 1.00
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol (2014) 1.00
Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS One (2011) 1.00
Lung cancer biomarkers: State of the art. J Carcinog (2013) 1.00
Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer. Expert Opin Med Diagn (2012) 0.98
Involvement of microRNAs in lung cancer biology and therapy. Transl Res (2011) 0.96
MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog (2010) 0.96
Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res (2014) 0.95
Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis (2012) 0.95
Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival. Int J Clin Exp Pathol (2014) 0.92
Can microRNAs improve the management of lung cancer patients? A clinician's perspective. Theranostics (2013) 0.92
Downregulation of microRNA-124 predicts poor prognosis in glioma patients. Neurol Sci (2014) 0.92
MicroRNA-dependent regulation of transcription in non-small cell lung cancer. PLoS One (2014) 0.91
MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. PLoS One (2012) 0.91
MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmgenomics Pers Med (2014) 0.91
Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol Ther (2013) 0.91
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer. Cancer (2011) 0.90
MicroRNAs - Important Molecules in Lung Cancer Research. Front Genet (2012) 0.90
Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (Sao Paulo) (2013) 0.90
Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling. Cancer Invest (2011) 0.89
Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons. Int J Mol Sci (2012) 0.88
Discovery of common SNPs in the miR-205/200 family-regulated epithelial to mesenchymal transition pathway and their association with risk for non-small cell lung cancer. Int J Mol Epidemiol Genet (2011) 0.87
microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer. Exp Ther Med (2012) 0.86
Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer. Med Sci Monit (2015) 0.85
The mutually regulatory loop of epithelial-mesenchymal transition and immunosuppression in cancer progression. Oncoimmunology (2015) 0.85
Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int J Mol Sci (2012) 0.85
miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein. Med Sci Monit (2015) 0.85
Epigenetic Therapy in Lung Cancer - Role of microRNAs. Front Oncol (2013) 0.84
Variation in dicer gene is associated with increased survival in T-cell lymphoma. PLoS One (2012) 0.84
Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth. J Cell Mol Med (2015) 0.83
Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology. BMC Cancer (2014) 0.83
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC). BMC Res Notes (2011) 0.82
miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. Am J Transl Res (2015) 0.82
Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer. Physiol Genomics (2014) 0.82
Small RNA sequencing for profiling microRNAs in long-term preserved formalin-fixed and paraffin-embedded non-small cell lung cancer tumor specimens. PLoS One (2015) 0.82
Multiclass cancer classification based on gene expression comparison. Stat Appl Genet Mol Biol (2014) 0.81
Systems biology approaches to develop innovative strategies for lung cancer therapy. Cell Death Dis (2014) 0.81
Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management. Patholog Res Int (2011) 0.81
Buccal microRNA dysregulation in lung field carcinogenesis: gender-specific implications. Int J Oncol (2014) 0.79
Detection of miRNAs with a nanopore single-molecule counter. Expert Rev Mol Diagn (2012) 0.79
Genomic features and computational identification of human microRNAs under long-range developmental regulation. BMC Genomics (2011) 0.78
MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features. Sci Rep (2016) 0.78
An argument for mechanism-based statistical inference in cancer. Hum Genet (2014) 0.77
MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer. Metabolomics (Los Angel) (2012) 0.77
Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma. Mol Med Rep (2015) 0.77
Characterizing dynamic regulatory programs in mouse lung development and their potential association with tumourigenesis via miRNA-TF-mRNA circuits. BMC Syst Biol (2013) 0.77
An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation. Sci Rep (2015) 0.76
Robust two-gene classifiers for cancer prediction. Genomics (2011) 0.76
MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1. Oncol Lett (2017) 0.75
Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. Int J Clin Exp Pathol (2015) 0.75
Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer. Onco Targets Ther (2016) 0.75
MicroRNA-3196 is inhibited by H2AX phosphorylation and attenuates lung cancer cell apoptosis by downregulating PUMA. Oncotarget (2016) 0.75
Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients. J Cancer Sci Ther (2014) 0.75
MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway. Sci Rep (2017) 0.75
Statistical analysis of a Bayesian classifier based on the expression of miRNAs. BMC Bioinformatics (2015) 0.75
The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway. Mol Cancer (2017) 0.75
snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma. PLoS One (2017) 0.75
Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles. Sci Rep (2017) 0.75
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol (2002) 7.12
Alternative mapping of probes to genes for Affymetrix chips. BMC Bioinformatics (2004) 3.56
Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med (2005) 3.35
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Reproducibility of oligonucleotide microarray transcriptome analyses. An interlaboratory comparison using chemostat cultures of Saccharomyces cerevisiae. J Biol Chem (2002) 2.72
Safety of thoracoscopic lobectomy in locally advanced lung cancer. Ann Surg Oncol (2011) 2.34
Design of oligonucleotides for microarrays and perspectives for design of multi-transcriptome arrays. Nucleic Acids Res (2003) 2.24
MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies. J Thorac Oncol (2015) 2.11
Concern WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 1.84
New weakly expressed cell cycle-regulated genes in yeast. Yeast (2005) 1.49
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res (2004) 1.45
Thoracoscopic extrapleural pneumonectomy for mesothelioma. Ann Thorac Surg (2011) 1.39
Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res (2003) 1.34
Does thoracoscopic pneumonectomy for lung cancer affect survival? Ann Thorac Surg (2010) 1.32
The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol (2004) 1.31
Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum (2013) 1.28
Transcriptome analysis documents induced competence of Bacillus subtilis during nitrogen limiting conditions. FEMS Microbiol Lett (2002) 1.26
Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Ann Thorac Surg (2012) 1.23
Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes (2007) 1.19
Is thoracoscopic pneumonectomy safe? Ann Thorac Surg (2009) 1.18
Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc Natl Acad Sci U S A (2003) 1.14
Molecular networks of human muscle adaptation to exercise and age. PLoS Genet (2013) 1.14
Improvement of galactose uptake in Saccharomyces cerevisiae through overexpression of phosphoglucomutase: example of transcript analysis as a tool in inverse metabolic engineering. Appl Environ Microbiol (2005) 1.14
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res (2004) 1.13
MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One (2012) 1.13
Thoracoscopic chest wall resection: what is its role? Ann Thorac Surg (2010) 1.12
Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol (2003) 1.10
Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J (2003) 1.06
Perioperative outcomes of thoracoscopic anatomic resections in patients with limited pulmonary reserve. J Thorac Cardiovasc Surg (2010) 1.05
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem (2011) 1.05
A 71-gene signature of TRAIL sensitivity in cancer cells. Mol Cancer Ther (2011) 1.03
Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome. PLoS One (2008) 1.01
Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS One (2011) 1.00
Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis (2004) 1.00
Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res (2003) 0.99
Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res (2003) 0.98
MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog (2010) 0.96
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy. Comp Funct Genomics (2004) 0.92
Independent validation of a model using cell line chemosensitivity to predict response to therapy. J Natl Cancer Inst (2013) 0.92
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. Cancer Gene Ther (2004) 0.92
Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc Diabetol (2012) 0.91
Overexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotype. PLoS One (2010) 0.91
Unique protein signature of circulating microparticles in systemic lupus erythematosus. Arthritis Rheum (2013) 0.90
Implementation of a gene expression index calculation method based on the PDNN model. Bioinformatics (2004) 0.89
Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res (2003) 0.89
Identification of novel genes regulated in the developing human ventral mesencephalon. Exp Neurol (2006) 0.88
Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression. J Thorac Cardiovasc Surg (2013) 0.88
MicroRNAs and esophageal cancer. J Gastrointest Oncol (2010) 0.88
Detection of microRNAs in dried serum blots. Anal Biochem (2010) 0.88
Lung cancer xenografting alters microRNA profile but not immunophenotype. Biochem Biophys Res Commun (2009) 0.86
Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol (2013) 0.86
Expression of microRNAs in the NCI-60 cancer cell-lines. PLoS One (2012) 0.86
Analysis of second primary lung cancers in the SEER database. J Surg Res (2010) 0.85
Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg (2011) 0.85
AT(1) receptor Gαq protein-independent signalling transcriptionally activates only a few genes directly, but robustly potentiates gene regulation from the β2-adrenergic receptor. Mol Cell Endocrinol (2010) 0.85
Advances in lung cancer surgery. J Carcinog (2012) 0.84
Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma. J Gastrointest Oncol (2013) 0.83
Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. Pancreas (2013) 0.83
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC). BMC Res Notes (2011) 0.82
Needle assembly malfunction: an unusual complication related to endobronchial ultrasound-guided transbronchial needle aspiration. J Bronchology Interv Pulmonol (2013) 0.81
Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc (2014) 0.80
Thoracoscopic organ suffusion for regional lung chemotherapy (preliminary results). Ann Thorac Surg (2009) 0.80
Mediastinal staging of non-small-cell lung cancer. Expert Rev Respir Med (2011) 0.79
[Advance in lung cancer surgery]. Zhongguo Fei Ai Za Zhi (2013) 0.77
Thoracoscopic maneuvers for chest wall resection and reconstruction. J Thorac Cardiovasc Surg (2012) 0.77
Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections. BMC Res Notes (2012) 0.76
Reply: To PMID 21704299. Ann Thorac Surg (2012) 0.75
Reply to "MiR-205 and miR-375 microRNA Assays to Distinguish Squamous Cell Carcinoma From Adenocarcinoma in Lung Cancer Biopsies". J Thorac Oncol (2015) 0.75
Right-to-left interatrial shunt with hypoxemia caused by a right atrial thrombus. Tex Heart Inst J (2007) 0.75
Reply to the editor. J Thorac Cardiovasc Surg (2013) 0.75
Calcified Mediastinal Metastasis of Ovarian Cancer Mimicking Broncholithiasis. J Bronchology Interv Pulmonol (2016) 0.75
Neural network predicts sequence of TP53 gene based on DNA chip. Bioinformatics (2002) 0.75
Esophago-pulmonary fistula manifesting as recurrent pneumonias and migrating mediastinal calcifications. Monaldi Arch Chest Dis (2017) 0.75
Lymphangioma presenting as hemoptysis in pregnancy. Am J Respir Crit Care Med (2014) 0.75